These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 450928)

  • 21. Preferential reaction of the carcinogen N-acetoxy-2-acetylaminofluorene with satellite DNA.
    Melchior WB; Beland FA
    Chem Biol Interact; 1984 Apr; 49(1-2):177-87. PubMed ID: 6722934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-hydroxy-2-acetylaminofluorene inhibition of rat live RNA polymerases.
    Herzog J; Serroni A; Briesmeister BA; Farber JL
    Cancer Res; 1975 Aug; 35(8):2138-44. PubMed ID: 1149028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical basis for the resistance of guinea pigs to carcinogenesis by 2-acetylaminofluorene.
    Kawajiri K; Yonekawa H; Hara E; Tagashira Y
    Biochem Biophys Res Commun; 1978 Dec; 85(3):959-65. PubMed ID: 736968
    [No Abstract]   [Full Text] [Related]  

  • 24. Mutagenicity of 7-iodo and 7-fluoro derivatives of N-hydroxy-and N-acetoxy-N-2-acetylaminofluorene in the Salmonella typhimurium assay.
    Santella RM; Fuchs RP; Grunberger D
    Mutat Res; 1979 May; 67(1):85-7. PubMed ID: 379638
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition by N-hydroxy-2-acetylaminofluorene of incorporation of (5-3H)orotic acid into RNA of two classes of nuclei from normal and regenerating liver.
    Glazer RI
    Biochim Biophys Acta; 1974 Sep; 361(3):361-6. PubMed ID: 4418149
    [No Abstract]   [Full Text] [Related]  

  • 26. Bacterial mutagenesis and host cell DNA damage by chemical carcinogens in the Salmonella/hepatocyte system.
    Staiano N; Erickson LC; Thorgeirsson SS
    Biochem Biophys Res Commun; 1980 Jun; 94(3):837-42. PubMed ID: 6994733
    [No Abstract]   [Full Text] [Related]  

  • 27. Preferential promutagenic lesions at exons 7-8 of human p53 genomic DNA induced by the direct-acting hepatocarcinogens N-nitroso-2-acetylaminofluorene and N-acetoxy-2-acetylaminofluorene.
    Ho YS; Lin JK
    Cancer Lett; 1995 Aug; 95(1-2):39-47. PubMed ID: 7656242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of modification by N-acetoxy-N-2-acetylaminofluorene on the level of DNA methylation.
    Salas CE; Pfohl-Leszkowicz A; Lang MC; Dirheimer G
    Nature; 1979 Mar; 278(5699):71-2. PubMed ID: 763353
    [No Abstract]   [Full Text] [Related]  

  • 29. Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems.
    Bartsch H; Malaveille C; Camus AM; Martel-Planche G; Brun G; Hautefeuille A; Sabadie N; Barbin A; Kuroki T; Drevon C; Piccoli C; Montesano R
    Mutat Res; 1980 Jul; 76(1):1-50. PubMed ID: 6993936
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhanced survival of ultraviolet-irradiated herpes simplex virus in carcinogen-pretreated cells.
    Lytle CD; Coppey J; Taylor WD
    Nature; 1978 Mar; 272(5648):60-2. PubMed ID: 203864
    [No Abstract]   [Full Text] [Related]  

  • 31. The mechanism by which heparin stimulates transcription in isolated rat liver nuclei. Polyribonucleotide elongation rates and the number of transcribing RNA polymerase molecules present.
    Coupar BE; Chesterton CJ
    Eur J Biochem; 1977 Oct; 79(2):525-33. PubMed ID: 923565
    [No Abstract]   [Full Text] [Related]  

  • 32. Varying degrees of susceptibility of inbred strains of rats to N-2-fluorenyldiacetamide hepatic carcinogenesis.
    Reuber MD
    Toxicol Appl Pharmacol; 1976 Sep; 37(3):525-30. PubMed ID: 973225
    [No Abstract]   [Full Text] [Related]  

  • 33. Hot spots of frameshift mutations induced by the ultimate carcinogen N-acetoxy-N-2-acetylaminofluorene.
    Fuchs RP; Schwartz N; Daune MP
    Nature; 1981 Dec; 294(5842):657-9. PubMed ID: 7031481
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of isolated rat liver RNApolymerases I and II by aminoacridines.
    Zoncheddu A; Accomando R; Calendi E; Orunesu M
    Experientia; 1980 Oct; 36(10):1151-2. PubMed ID: 7418788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear inclusions and other ultrastructural aspects in the liver of animals treated with n-2-acetylaminofluorene.
    Dobre MA; Moraru I; Cotutiu C; Moţoc F
    Pathol Eur; 1976; 11(1):63-8. PubMed ID: 934702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased fidelity of DNA polymerase activity during N-2-fluorenylacetamide hepatocarcinogenesis.
    Chan JY; Becker FF
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):814-8. PubMed ID: 284402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody against a stimulatory factor of RNA polymerase II inhibits nuclear RNA synthesis.
    Ueno K; Sekimizu K; Mizuno D; Natori S
    Nature; 1979 Jan; 277(5692):145-6. PubMed ID: 366437
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of N-acetoxy-2-acetylaminofluorene and N'-nitro-N-nitrosoguanidine on nuclear DNA synthesis in rat liver.
    Guzzo GJ; Glazer RI
    Cancer Res; 1976 Mar; 36(3):1041-8. PubMed ID: 1253167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of hepatic ribonucleic acid polymerase activities by N-hydroxy-2-acetlaminofluorene and N-acetoxy-2-acetylaminofluorene.
    Glazer RI; Glass LE; Menger FM
    Mol Pharmacol; 1975 Jan; 11(1):36-43. PubMed ID: 1090803
    [No Abstract]   [Full Text] [Related]  

  • 40. A macromolecular inhibitor of rat liver DNA-dependent RNA polymerases.
    Antonoglou O; Salakidou H; Haralambidou E; Trakatellis A
    Biochim Biophys Acta; 1977 Feb; 474(3):467-77. PubMed ID: 831828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.